Bruni, S., Mauro, F. L., Naveiro, S., Cordo Russo, R. I., Dupont, A., Mercogliano, M. F., & Schillaci, R. (2024). Blocking soluble TNF to Improve potency of trastuzumab deruxtecan by increasing internalization and antitumor innate immune response in a resistant HER2-positive breast cancer model. Web
Citación estilo ChicagoBruni, Sofia, Florencia Luciana Mauro, Sofía Naveiro, Rosalia Ines Cordo Russo, Agustina Dupont, María Florencia Mercogliano, and Roxana Schillaci. Blocking Soluble TNF to Improve Potency of Trastuzumab Deruxtecan By Increasing Internalization and Antitumor Innate Immune Response in a Resistant HER2-positive Breast Cancer Model. 2024.
Cita MLABruni, Sofia, et al. Blocking Soluble TNF to Improve Potency of Trastuzumab Deruxtecan By Increasing Internalization and Antitumor Innate Immune Response in a Resistant HER2-positive Breast Cancer Model. 2024.